Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Role of the mitochondrial protein cyclophilin D in skin wound healing and collagen secretion
Ritu Bansal, … , Etty Bachar-Wikstrom, Jakob D. Wikstrom
Ritu Bansal, … , Etty Bachar-Wikstrom, Jakob D. Wikstrom
Published April 2, 2024
Citation Information: JCI Insight. 2024;9(9):e169213. https://doi.org/10.1172/jci.insight.169213.
View: Text | PDF
Research Article Dermatology

Role of the mitochondrial protein cyclophilin D in skin wound healing and collagen secretion

  • Text
  • PDF
Abstract

Central for wound healing is the formation of granulation tissue, which largely consists of collagen and whose importance stretches past wound healing, including being implicated in both fibrosis and skin aging. Cyclophilin D (CyD) is a mitochondrial protein that regulates the permeability transition pore, known for its role in apoptosis and ischemia-reperfusion. To date, the role of CyD in human wound healing and collagen generation has been largely unexplored. Here, we show that CyD was upregulated in normal wounds and venous ulcers, likely adaptive as CyD inhibition impaired reepithelialization, granulation tissue formation, and wound closure in both human and pig models. Overexpression of CyD increased keratinocyte migration and fibroblast proliferation, while its inhibition reduced migration. Independent of wound healing, CyD inhibition in fibroblasts reduced collagen secretion and caused endoplasmic reticulum collagen accumulation, while its overexpression increased collagen secretion. This was confirmed in a Ppif-KO mouse model, which showed a reduction in skin collagen. Overall, this study revealed previously unreported roles of CyD in skin, with implications for wound healing and beyond.

Authors

Ritu Bansal, Monica Torres, Matthew Hunt, Nuoqi Wang, Margarita Chatzopoulou, Mansi Manchanda, Evan P. Taddeo, Cynthia Shu, Orian S. Shirihai, Etty Bachar-Wikstrom, Jakob D. Wikstrom

×

Figure 4

Skin collagen protein expression and fibrils are reduced in Ppif-KO mice while mitochondria appear normal.

Options: View larger image (or click on image) Download as PowerPoint
Skin collagen protein expression and fibrils are reduced in Ppif-KO mice...
(A) Cartoon depicting the experimental setup. (B–E) Representative TEM micrographs of mitochondrial morphology (arrows) in keratinocytes (B) and fibroblasts (D), and quantification (mean ± SD) of mitochondrial area (C–E). n (number of mouse skin samples) = 7. Arrows indicate mitochondria. (F and G) Representative micrographs of collagen fibril morphology and density (arrows) as well as quantification (mean ± SEM) in fibroblasts. Note the reduction in fibril size and density. n = 7. (H–J) IHC images (H), zooms (I), and quantification (J) (mean ± SD) of skin sections stained with the main collagen types 1/3 and upstream collagen signaling marker α-SMA, CyD, and IgG. n = 3 mice per condition with 3 different visual fields. Scale bars: 1 μm (TEM); 100 μm; and 50 μm (IHC). Two-way ANOVA. n = 3. ****P < 0.0001; ***P < 0.001; **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts